Adjuvant Global Health Technology Fund, L.P. - Aug 23, 2023 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role
10%+ Owner
Signature
Adjuvant Global Health Technology Fund, L.P., By: Adjuvant Capital GP, L.P., its sole general partner, By: Adjuvant Capital Management, L.L.C., its sole general partner, By: Kabeer Aziz, Secretary, /s/ Kabeer Aziz
Stock symbol
ANTX
Transactions as of
Aug 23, 2023
Transactions value $
-$6,400
Form type
4
Date filed
9/15/2023, 05:17 PM
Previous filing
Jun 24, 2022
Next filing
Sep 29, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANTX Common Stock Sale -$5.38K -336 -0.02% $16.00 2.18M Sep 13, 2023 Direct F1, F2
transaction ANTX Common Stock Sale -$1.02K -64 -0.02% $16.00 412K Sep 13, 2023 By Adjuvant Global Health Technology Fund DE, L.P.( F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2022.
F2 Shares held directly by Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund"). The sole general partner of AGHT Fund is Adjuvant Capital GP, L.P. ("AC GP") and the sole general partner of AC GP is Adjuvant Capital Management, L.L.C. ("AC MGMT"). Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.
F3 Shares held directly by Adjuvant Global Health Technology Fund DE, L.P. ("AGHT Fund DE"). The sole general partner of AGHT Fund DE is AC GP and the sole general partner of AC GP is AC MGMT. Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.